Access the full text.
Sign up today, get DeepDyve free for 14 days.
Marko Jelavić, Z. Babić, H. Pintarić (2015)
Metabolic syndrome: influence on clinical severity and prognosis in patients with acute ST-elevation myocardial infarction treated with primary percutaneous coronary interventionActa Cardiologica, 70
T. Morishita, Hiroyasu Uzui, Y. Mitsuke, H. Tada (2022)
Relationship of body mass index to clinical outcomes after percutaneous coronary interventionEuropean Journal of Clinical Investigation, 52
Chong-Do Lee, D. Jacobs, P. Schreiner, C. Iribarren, A. Hankinson (2007)
Abdominal obesity and coronary artery calcification in young adults: the Coronary Artery Risk Development in Young Adults (CARDIA) Study.The American journal of clinical nutrition, 86 1
M. Jelavic, Z. Babić, H. Pintarić (2016)
The importance of two metabolic syndrome diagnostic criteria and body fat distribution in predicting clinical severity and prognosis of acute myocardial infarctionArchives of Medical Science : AMS, 13
T. Coutinho, K. Goel, Daniel Sa, C. Kragelund, A. Kanaya, M. Zeller, Jong-Seon Park, L. Køber, C. Torp‐Pedersen, Y. Cottin, L. Lorgis, Sang-hee Lee, Young-Jo Kim, Randal Thomas, V. Roger, V. Somers, F. Lopez‐Jimenez (2011)
Central obesity and survival in subjects with coronary artery disease: a systematic review of the literature and collaborative analysis with individual subject data.Journal of the American College of Cardiology, 57 19
(2010)
Korea acute myocardial infarction registry investigators. Obesity paradox in Korean patients undergoing primary percutaneous coronary intervention in ST- segment elevation myocardial infarction
M Kosuge, K Kimura, S Kojima (2008)
Japanese acute coronary syndrome study (JACSS) investigators. Impact of body mass index on in‐hospital outcomes after percutaneous coronary intervention for ST segment elevation acute myocardial infarction, 72
Dear Editor,The study of Morishita et al. investigated relationships between body mass index (BMI) and clinical outcomes following percutaneous coronary intervention (PCI) in patients with chronic coronary artery disease (CAD).1 They reviewed 1104 subjects who underwent PCI between 2006 and 2015, and divided them by BMI into three groups: lean (<18.5 kg/m2), normal (18.5–24.9 kg/m2) and overweight/obese (≥25 kg/m2). The primary endpoint was all‐cause mortality, and the secondary endpoint was 3‐point major adverse cardiovascular events (MACE). The authors found lean category was associated with adverse outcomes among CAD patients. An obesity paradox regarding the independent association of elevated BMI with reduced mortality after PCI is evident in both males and females.Their interesting findings are consistent with the results of our prospective studies about the influence of metabolic syndrome (MetS) and various obesity indices on clinical severity and prognosis of acute ST‐elevation myocardial infarction (STEMI) treated with primary PCI.2,3 We found that MetS increased the risk of >1 significantly stenosed coronary arteries (CAs), visceral obesity increased the risk of dyspnoea (Body adiposity index, BAI), total in‐hospital complications (Conicity index, C index), significant proximal/middle coronary segments stenosis and Gensini score ≥20 (waist‐to‐hip ratio, WHR), and of heart failure (waist‐to‐height ratio, WHtR), while overall obesity
European Journal of Clinical Investigation – Wiley
Published: Aug 1, 2022
Read and print from thousands of top scholarly journals.
Already have an account? Log in
Bookmark this article. You can see your Bookmarks on your DeepDyve Library.
To save an article, log in first, or sign up for a DeepDyve account if you don’t already have one.
Copy and paste the desired citation format or use the link below to download a file formatted for EndNote
Access the full text.
Sign up today, get DeepDyve free for 14 days.
All DeepDyve websites use cookies to improve your online experience. They were placed on your computer when you launched this website. You can change your cookie settings through your browser.